Abstract:ERK activation is enhanced by the scaffolding proteins KSR and MP1, localized near the cell membrane and late endosomes respectively, but little is known about their dynamic interplay. We develop here a mathematical model with ordinary differential equations to describe the dynamic activation of EGFR-ERK signaling under a conventional pathway without scaffolds, a KSR-scaffolded pathway, and an MP1-scaffolded pathway, and their impacts were examined under the influence of the endosomal regulators, Cbl-CIN85 and Endophilin A1. This new integrated model, validated against experimental results and computational constraints, shows that changes of ERK activation and EGFR endocytosis in response to EGF concentrations (i.e ligand sensitivity) depend on these scaffold proteins and regulators. The KSR-scaffolded and the conventional pathways act synergistically and are sensitive to EGF stimulation. When the KSR level is high, the sensitivity of ERK activation from this combined pathway remains low when Cbl-CIN85 level is low. But, such sensitivity can be increased with increasing levels of Endophilin if Cbl-CIN85 level becomes high. However, reduced KSR levels already present high sensitivity independent of Endophilin levels. In contrast, ERK activation by MP1 is additive to that of KSR but it shows little ligand-sensitivity under high levels of EGF. This can be partly reversed by increasing level of Endophilin while keeping Cbl-CIN85 level low. Further analyses showed that high levels of KSR affect ligand-sensitivity of EGFR endocytosis whereas MP1 ensures the robustness of endosomal ERK activation. These simulations constitute a multi-dimensional exploration of how EGF-dependent EGFR endocytosis and ERK activation are dynamically affected by scaffolds KSR and MP1, co-regulated by Cbl-CIN85 and Endophilin A1. Together, these results provide a detailed and quantitative demonstration of how regulators and scaffolds can collaborate to fine-tune the ligand-dependent sensitivity of EGFR endocytosis and ERK activation which could underlie differences during normal physiology, disease states and drug responses.

Regulation Of Egf Receptor Signaling By The Marvel Domain-Containing Protein Cklfsf8

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

[Regulation on EGFR Function Via Its Interacting Proteins and Its Potential Application].

The clathrin adaptor complex-1 and Rab12 regulate post-golgi trafficking of WT epidermal growth factor receptor (EGFR)

Regulation of EGF-induced ERK/MAPK Activation and EGFR Internalization by G Protein-Coupled Receptor Kinase 2.

Carboxy-Terminal Truncations Of Epidermal Growth-Factor (Egf) Receptor Affect Diverse Egf-Induced Cellular-Responses

[Cross-Talk Between Notch1 and Epidermal Growth Factor Receptor Signalling in Regulating Cell Proliferation of Human Tongue Squamous Carcinoma Cells].

Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals

Spatial and signaling overlap of growth factor receptor systems at clathrin-coated sites

An EGF Receptor/ral-Gtpase Signaling Cascade Regulates C-Src Activity and Substrate Specificity.

Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Epidermal growth factor receptor (EGFR) and its signal transduction

Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin

Regulation Of Egf-Stimulated Egf Receptor Endocytosis During M Phase

EGF Regulates the Interaction of Tks4 with Src through Its SH2 and SH3 Domains

Low-affinity ligands of the epidermal growth factor receptor are long-range signal transmitters during collective cell migration of epithelial cells

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

Fyn and TOM1L1 Are Recruited to Clathrin-Coated Pits and Regulate Akt Signaling.

Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling

LAMC2 Promotes EGFR Cell Membrane Localization and Acts As a Novel Biomarker for Tyrosine Kinase Inhibitors (tkis) Sensitivity in Lung Cancer

Fgf-Receptor Substrate 2 Functions As A Molecular Sensor Integrating External Regulatory Signals into the Fgf Pathway